Picture of Sutro Biopharma logo

STRO — Sutro Biopharma News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

Sutro Biopharma Inc reports results for the quarter ended September 30 - Earnings Summary

* Sutro Biopharma Inc  STRO.OQ  reported a quarterly
adjusted loss
of 59 cents​​ per share for the quarter ended September 30,
higher than the same quarter last year, when the company
reported EPS of -81 cents.  The mean expectation of
eleven analysts for the quarter was for a loss of 73 cents per
share. Wall Street expected results to range from -89 cents
to -54 cents per share.
    * Revenue fell 49.7% to $8.52 million from a year ago;
analysts
expected $15.25 million. 
    * Sutro Biopharma Inc's reported EPS for the quarter was a
loss
of 59 cents​.
    * The company reported a quarterly loss of $48.79 million.
    * Sutro Biopharma Inc shares had risen by 17.9% this
quarter and
lost 4.9% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 2.2%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 10 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Sutro Biopharma
Inc is 11.50 
This summary was machine generated from LSEG data November 14 at
04:07 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.73          -0.59          Beat
 Jun. 30 2024      -0.92          -0.59          Beat
 Mar. 31 2024      -0.92          -0.95          Missed
 Dec. 31 2023      -0.82          0.52           Beat

Recent news on Sutro Biopharma

See all news